Overview
Coronaviruses are a large family of enveloped, single-stranded RNA viruses named for the crown-like spikes on their surface, and they infect humans and a wide range of animals. In people they cause illnesses ranging from mild upper respiratory infections similar to the common cold to severe respiratory diseases, including Middle East respiratory syndrome (MERS), severe acute respiratory syndrome (SARS), and coronavirus disease 2019 (COVID-19), which is caused by SARS-CoV-2. Their surface spike glycoprotein mediates entry into host cells and is a primary target for immunity, vaccines, and therapeutics, while their RNA genomes are prone to mutation, contributing to viral evolution and the emergence of new variants. Research in this journal focuses heavily on SARS-CoV-2 and COVID-19, including the molecular evolution and characterization of the virus through spike-gene sequence analysis, narrative reviews of COVID-19, and the role of animals as potential sources or victims of the virus. Further studies examine cellular pathogenesis and therapy, immune modulation with interferon-gamma, neutralizing antibodies and convalescent plasma, dietary and supplement-based approaches, the clinical effects of treatments such as hydroxychloroquine, and non-pharmaceutical measures including masking and social distancing. Across this work, understanding viral evolution, transmission, immunity, and treatment remains central to the scientific response to coronavirus outbreaks.
Research published in this journal
12 peer-reviewed articles, ranked by relevance. Each links to its DOI.
SARS-CoV-2 affected cells Pathogeny and Therapy
The Novel Coronavirus 2019 (COVID-19): A Narrative Review
Animals in the COVID-19 Era: Between Being a source, Victims, or Maybe our Hope to Overcome it!
SARS-Corona Virus-2 Origin and Treatment, From Coffee to Coffee: A Double-Edged Sword
Reducing COVID-19 Risk through Dietary Supplementation of Plant Mannose Binding Lectins
Molecular Evolution of the Novel Coronavirus SARS-CoV-2
Marginal SARS-CoV-2 Spike Protein Increases Interferon and Balances Cytokine Gene Expression
Biomedical Infophysical Models of Filtering Ghost Airflows by Wearing Masks and Maintaining Social Distancing to Prevent COVID-19 and Reopen All Systems after Shutdowns (Lockdowns)
Use of Immune Modulator Interferon-Gamma to Support Combating COVID-19 Pandemic
Presentation of Neutralizing Antibodies in Single- or Pooled-Convalescent Immune Plasma from Donors to Prevent the Current SARS-CoV-2 Pandemic
Effect of Hydroxychloroquine on Clinical Improvement and Mortality Among Patients with COVID-19 Admitted to Four General Hospitals in Saudi Arabia
How this research is being cited
The 12 articles above have been cited 36 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2025 · Inflammopharmacology
-
2025 · Inflammopharmacology
-
2024 · German Journal of Pharmaceuticals and Biomaterials
-
R. Paulino-Ramírez et al. · 2023 · International Journal of Environmental Research and Public Health
-
2023 · Revista Brasileira de Farmacognosia
-
2023 · Revista Brasileira de Farmacognosia
-
2023 · International Journal of Environmental Research and Public Health
-
Satadal Das et al. · 2023 · International Journal of Applied Biology
A sample of recent works citing this journal's research on Coronaviruses, linking to each citing work.